|
|
|
Bio-Key Intl Inc 
|
4.31 0.13 (0.03%) |
01-22 16:00 |
Open: |
4.15 |
Pre close: |
4.18 |
Target:
|
5.30
|
High: |
4.33 |
Low: |
4.11 |
Resistance:
|
4.54
5.30
|
Volume: |
439,188 |
Market Cap: |
34M |
Support:
|
3.80
3.34
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
4.10
 |
MACD |
MACD(12,26):
|
0.17  |
MA(20): |
3.78  |
Signal(12,26,9): |
0.11  |
MA(100): |
3.65  |
Stochastic Oscillator |
%K(14,3):
|
74.07  |
MA(250): |
5.14  |
%D(3): |
77.56  |
Average Volume(K) |
3-Month: |
76081
|
52-Week |
High:
|
20.64 |
10-Days: |
80528 |
Low: |
2.75 |
RSI |
RSI(14):
|
69.64  |
Change(%): |
-14.5 |
Financials, Statistics and Valuation |
EPS |
-2.293 |
Return on Equity (ttm) |
-123.4 |
Shares Out. (M) |
7.79 |
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-21.4 |
Shares Float (M) |
6.80 |
EPS Est. Next Year |
-0.400 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.11 |
EPS Est. Next Quarter |
-0.120 |
Qtrly Rev. Growth |
108.4 |
% Held by Institutions |
3.51 |
Forward EPS |
-0.730 |
Gross Profit (p.s.) |
-0.025 |
Shares Short (K) |
137 |
Book Value (p.s.) |
2.780 |
EBITDA (p.s.) |
-0.748 |
P/E |
-1.88 |
Sales Per Share |
0.297 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.55 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-3.66 |
P/S |
14.53 |
Operating Margin |
-257.53 |
Levered Free Cash Flow
(M) |
1.05 |
P/CF |
-9.17 |
|
|
|
|
|